RNA m6a Methylation Regulator Expression in Castration

Using mass spectrometry and RNA sequencing, this study profiles the dynamic m6A regulator expression patterns in prostate cancer. It identifies specific regulators whose expression significantly changes during cancer development, therapy resistance, and progression to advanced stages like castration-resistant prostate cancer.

N6-methyladenosine ( m6A ) methylation , a prevalent epitranscriptomic modification, plays a crucial role in regulating mRNA expression , stability, and translation in mammals. M6A regulators have gained attention for their potential implications in tumorigenesis and clinical applications, such as cancer diagnosis and therapeutics. The existing literature predominantly addresses m6A regulators in ...
RNA m6a Methylation Regulator Expression in Castration

The existing literature predominantly addresses m6A regulators in the context of primary prostate cancer (PCa). However, a notable gap in the knowledge emerges regarding the dynamic expression patterns of these regulators as PCa progresses towards the castration-resistant stage (CRPC).
Abstract N6-methyladenosine ( m6A ) methylation , a prevalent epitranscriptomic modification, plays a crucial role in regulating mRNA expression , stability, and translation in mammals. M6A regulators have gained attention for their potential implications in tumorigenesis and clinical applications, such as cancer diagnosis and therapeutics.

RNA m6a Methylation Regulator Expression in Castration
The existing literature predominantly addresses m6A regulators in the context of primary prostate cancer (PCa). However, a notable gap in the knowledge emerges regarding the dynamic expression patterns of these regulators as PCa progresses towards the castration-resistant stage (CRPC).
Liyanage, Chamikara, Fernando, Achala, Chamberlain, Audrey, Moradi, Afshin, Batra, Jyotsna (2024) RNA m6a Methylation Regulator Expression in Castration-Resistant Prostate Cancer Progression and Its Genetic Associations. Cancers, 16 (7), pp.Article number: 1303. 1 citations on Web of Science 1 citations on ScopusView on ePrintsRNA m6a Methylation Regulator Expression in Castration-Resistant ...

RNA m6a Methylation Regulator Expression in Castration
Liyanage C, Fernando A, Chamberlain A, Moradi A, Batra J. RNA m6a Methylation Regulator Expression in Castration-Resistant Prostate Cancer Progression and Its Genetic Associations.
N6-methyladenosine ( m6A ) methylation , a prevalent epitranscriptomic modification, plays a crucial role in regulating mRNA expression , stability, and translation in mammals. M6A regulators have gained attention for their potential implications in tumorigenesis and clinical applications, such as cancer diagnosis and therapeutics.

Key Details About Rna M6A Methylation Regulator Expression In Castration Resistant
In this study, we analyzed the characteristic expression of m 6 A regulators in PCa and castration-resistant prostate cancer (CRPC). UALCAN and cBioPortal were used to estimate the clinical value and genetic alterations of m 6 A regulators , respectively.







In conclusion, METTL3 activated the ERK pathway and induced the resistance to Enzalutamide by regulating the m6A level of critical gene transcription in the ERK pathway.